Product line · Glucoraphanin-Myrosinase Complex
EXTRABROC® SFN Series
EXTRABROC® SFN Series is a Glucoraphanin-Myrosinase Complex: a sulforaphane-generating ingredient built from glucoraphanin, myrosinase and a food-grade stabilizing component. It comes in three models — SFN-1, SFN-5 and SFN-10 — with customizable specifications.
What the SFN Series is
EXTRABROC® SFN is a Glucoraphanin-Myrosinase Complex, built from glucoraphanin, myrosinase and a food-grade stabilizing component. Glucoraphanin is the precursor found in broccoli seeds; myrosinase is the enzyme that converts it to sulforaphane. The series includes SFN-1, SFN-5 and SFN-10, each with its own specification, and customizable specifications.
The complex uses the patented GRN-Myrosinase Co-Delivery System: China patent ZL202211488217.2 and Japan Patent No. 7379533. See Quality & IP.

Models and nominal specifications
| Item | SFN-1 | SFN-5 | SFN-10 |
|---|---|---|---|
| Product name | EXTRABROC® Glucoraphanin-Myrosinase Complex (SFN-1) | EXTRABROC® Glucoraphanin-Myrosinase Complex (SFN-5) | EXTRABROC® Glucoraphanin-Myrosinase Complex (SFN-10) |
| Sulforaphane | ≥1.0% (HPLC) | ≥5.0% (HPLC) | ≥10.0% (HPLC) |
| Appearance | Light Yellow Fine Powder | Light Yellow Fine Powder | Light Yellow Fine Powder |
| Particle size | 90% through 180 μm | 90% through 180 μm | 90% through 180 μm |
| Bulk density | ≥0.25 g/ml | ≥0.25 g/ml | ≥0.30 g/ml |
| Moisture | ≤8.0% | ≤8.0% | ≤8.0% |
| Ash | ≤12.0% | ≤12.0% | ≤14.0% |
| Package | 20 kg per bag, or according to customer requirements | 20 kg per bag, or according to customer requirements | 20 kg per bag, or according to customer requirements |
| MOQ | 5 kg minimum | 5 kg minimum | 5 kg minimum |
| Storage | Cool, dark, airtight, original package | Cool, dark, airtight, original package | Cool, dark, airtight, original package |
| Shelf life | 2 years when properly stored | 2 years when properly stored | 2 years when properly stored |
Microbiology and heavy metals
| Item | SFN-1 | SFN-5 | SFN-10 |
|---|---|---|---|
| Total aerobic colony count | ≤10000 cfu/g | ≤10000 cfu/g | ≤10000 cfu/g |
| Yeasts and molds | ≤1000 cfu/g | ≤1000 cfu/g | ≤1000 cfu/g |
| Escherichia coli | Negative | Negative | Negative |
| Salmonella | Negative | Negative | Negative |
| Lead | ≤0.5 μg/g | ≤0.5 μg/g | ≤0.5 μg/g |
| Arsenic (inorganic) | ≤1.5 μg/g | ≤1.5 μg/g | ≤1.5 μg/g |
| Mercury (total) | ≤1.5 μg/g | ≤1.5 μg/g | ≤1.5 μg/g |
| Methylmercury (as Hg) | ≤0.2 μg/g | ≤0.2 μg/g | ≤0.2 μg/g |
| Cadmium | ≤0.5 μg/g | ≤0.5 μg/g | ≤0.5 μg/g |
Composition listed in the product documents: broccoli seed extract, horseradish powder, vitamin C, calcium carbonate and silicon dioxide; the SFN-1 and SFN-5 documents also list maltodextrin. The exact list follows the selected model and document version. Sulforaphane is assayed by HPLC at 245 nm after the sample preparation described in the Buyer FAQ.
Documents for the SFN Series
The nominal specifications above are public, and a sample COA and the certificates can be viewed online. Batch COAs and the technical dossier are available on request for the model you select.
Formats and handling
Use the SFN Series in powders, tablets and other solid formats; it is not recommended for liquids. The powder absorbs moisture: keep production and storage areas below 60% relative humidity and below 28 °C. Confirm suitability for your formulation and process in your own trials. Fushan can provide technical guidance on powder granulation and flowability.
Storage
Unopened: cool, dark, airtight, in the original package; two-year shelf life per TDS and label when properly stored. Opened: tie the inner PE bag closed and keep it sealed below 28 °C and 50% relative humidity.
In-vitro conversion
EXTRABROC® SFN has a glucoraphanin-to-sulforaphane conversion rate of ≥55% in simulated gastric fluid (in vitro; pH 3.5, 37 °C, 120 min, with pepsin). This is a laboratory result, not a human conversion or absorption rate. How to read the figures.
ZHIYINGUOSU, a Fushan finished product made with EXTRABROC® SFN-5, is the intervention product in the clinical studies Fushan lists. The studies concern the finished product, not every ingredient model. See the study records.
Evaluate SFN-1, SFN-5 or SFN-10 for your formulation.
Share your target market, finished-product format and preferred model. Specifications, COAs and test reports are available on request.